Ignite Creation Date:
2024-05-06 @ 3:57 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02415907
Status:
COMPLETED
Last Update Posted:
2015-07-20
First Post:
2015-04-07
Brief Title:
Investigating the Absorption Metabolism and Excretion AME of Idalopirdine
Sponsor:
H Lundbeck AS
Organization:
H Lundbeck AS
Study Overview
Official Title:
Interventional Open-label Two Single Dose Fixed-sequence Study Investigating the Absorption Metabolism and Excretion AME of Idalopirdine Following a Single Oral Dose of Lu AF67708 Ethyl-1-14C-Idalopirdine and Lu AF67709 Benzyl-7-14C-Idalopirdine in Healthy Men
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigating the absorption metabolism and excretion of radio labelled single doses of idalopirdine in healthy men
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2013-004001-28 | EUDRACT_NUMBER | None | None |